1. An Industry Perspective on the 2017 EMA Guideline on First‐in‐Human and Early Clinical Trials. Issue 4 (29th December 2017) Authors: DeGeorge, Joseph; Robertson, Sarah; Butler, Lynne; Derzi, Mazin; Stoch, S. Aubrey; Diaz, Dolores; Hartke, James; Guzzie‐Peck, Peggy; Mortimer‐Cassen, Elisabeth; Bogdanffy, Matthew; Will, Yvonne; Greene, Nigel Journal: Clinical pharmacology & therapeutics Issue: Volume 103:Issue 4(2018) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fit for Purpose Assessment: A New Direction for IACUCs. (4th May 2022) Authors: Kinter, Lewis B; Johnson, David K; Weichbrod, Robert H; Prentice, Ernest D; Simmonds, Richard C; Houghton, Paul W; Whitney Jr, Robert A; DeGeorge, Joseph; DeHaven, W Ron; Kramer, Klaas; DeTolla, Louis Journal: ILAR journal Issue: Volume 62:Number 3(2021) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacogenomic data submissions to the FDA: non-clinical case studies. (1st July 2004) Authors: Leighton, John K; DeGeorge, Joseph; Jacobson-Kram, David; MacGregor, James; Mendrick, Donna; Worobec, Alexandra Journal: Pharmacogenomics Issue: Volume 5:Number 5(2004) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗